First Trust Advisors
HRMY icon

First Trust Advisors’s Harmony Biosciences HRMY Stock Holding History

First Trust Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.94M Buy
190,574
+86,025
+82% +$2.71M ﹤0.01% 1389
2026
Q1 		$2.93M Sell
104,549
-50,805
-33% -$1.67M ﹤0.01% 1746
2025
Q4 		$5.81M Buy
155,354
+42,138
+37% +$1.39M ﹤0.01% 1330
2025
Q3 		$3.12M Sell
113,216
-8,990
-7% -$310K ﹤0.01% 1624
2025
Q2 		$3.86M Buy
122,206
+22,009
+22% +$708K ﹤0.01% 1494
2025
Q1 		$3.33M Sell
100,197
-69,212
-41% -$2.48M ﹤0.01% 1534
2024
Q4 		$5.83M Buy
169,409
+121,810
+256% +$4.19M 0.01% 1277
2024
Q3 		$1.9M Sell
47,599
-21,823
-31% -$767K ﹤0.01% 1792
2024
Q2 		$2.09M Buy
69,422
+57,327
+474% +$1.72M ﹤0.01% 1690
2024
Q1 		$406K Sell
12,095
-23,152
-66% -$743K ﹤0.01% 2184
2023
Q4 		$1.14M Buy
35,247
+24,783
+237% +$692K ﹤0.01% 1945
2023
Q3 		$343K Buy
+10,464
New +$363K ﹤0.01% 2224
2023
Q2 		– Sell
-86,174
Closed -$2.81M – 2389
2023
Q1 		$2.81M Sell
86,174
-117,579
-58% -$5.35M ﹤0.01% 1535
2022
Q4 		$11.2M Buy
203,753
+12,934
+7% +$711K 0.01% 931
2022
Q3 		$8.45M Buy
190,819
+22,374
+13% +$1.09M 0.01% 999
2022
Q2 		$8.21M Buy
168,445
+6,045
+4% +$272K 0.01% 1020
2022
Q1 		$7.9M Buy
162,400
+47,775
+42% +$1.95M 0.01% 1120
2021
Q4 		$4.89M Buy
+114,625
New +$4.57M ﹤0.01% 1376
2020
Q4 		– Sell
-61,030
Closed -$2.07M – 2366
2020
Q3 		$2.07M Buy
+61,030
New +$2.23M ﹤0.01% 1353

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's HRMY Position: Q2 2026 in Review

First Trust Advisors increased its Harmony Biosciences (HRMY) stake by 82% in Q2 2026, buying an estimated $2.71M and bringing the position to 190,574 shares worth $6.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

First Trust Advisors first reported a position in HRMY in Q3 2020 and has held it in 19 quarters since. The position peaked at $11.2M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • First Trust Advisors held 190,574 shares of Harmony Biosciences worth $6.94M as of Q2 2026.
  • First Trust Advisors bought 86,025 Harmony Biosciences shares in Q2 2026, an estimated $2.71M.
  • Harmony Biosciences made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1389 holding.
  • First Trust Advisors first reported a position in Harmony Biosciences in Q3 2020 and has held it in 19 quarters since.
  • First Trust Advisors's Harmony Biosciences position peaked at $11.2M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.